Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants

Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants

Background: Next-generation sequencing-based genetic testing represents a great opportunity to identify hereditary predispositions to specific pathological conditions and to promptly implement health surveillance or therapeutic protocols in case of disease. The term secondary finding refers to the a...

Full description

Bibliographic Details
Main Authors: Stefania Martone, Autilia Tommasina Buonagura, Roberta Marra, Barbara Eleni Rosato, Federica Del Giudice, Ferdinando Bonfiglio, Mario Capasso, Achille Iolascon, Immacolata Andolfo, Roberta Russo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Genetics
Subjects:
secondary findings
clinical exome
genetic testing
ACMG actionable genes
NGS testing
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.956723/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.956723/full

Similar Items